Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
Browsing Category

Small Cap

Small Cap

Group By Ticker
Sort By
Newest | Oldest
Read More
2 minute read
  • Events
  • Interview
  • Management
  • News
  • Small Cap

EXCLUSIVE: Chromadex CEO To Ring Nasdaq Closing Bell, Talks Walmart Product Launch

By Wayne Duggan
Today, 2:22 AM
Chromadex Corp (NASDAQ: CDXC) is participating in the Nasdaq’s closing bell ceremony on Thursday afternoon to celebrate its five-year anniversary of trading on the exchange.

CDXC

Read More
2 minute read
  • General
  • Health Care
  • News
  • Penny Stocks
  • Small Cap

CAN-FITE AHEAD OF SCHEDULE IN ITS FIGHT TO TREAT NASH AND LESSEN THE NEED FOR LIVER TRANSPLANTS

By Mark Gilman
Today, 2:22 AM
Nonalcoholic steatohepatitis (NASH) is the leading cause of disease leading to liver transplants among women and the second-leading cause for liver transplants overall. In addition, NASH is expected to become the leading indicator for liver transplants in men.

CANF

Read More
1 minute read
  • Long Ideas
  • Movers
  • Penny Stocks
  • Small Cap
  • Trading Ideas

Why Castor Maritime Stock Is Moving Today

By Henry Khederian
Today, 2:22 AM
Castor Maritime Inc (NASDAQ: CTRM) shares are trading higher by 18.3% at $3.69 Thursday morning after the company reported first-quarter EPS and sales results were up year-over-year.

CTRM

Read More
3 minute read
  • Commodities
  • Earnings
  • Eurozone
  • Global
  • Intraday Update
  • Markets
  • News
  • Penny Stocks
  • Small Cap

Mid-Morning Market Update: Markets Open Lower; JM Smucker Posts Upbeat Q4 Profit

By Lisa Levin
Today, 2:22 AM
Following the market opening Thursday, the Dow traded down 0.28% to 34,502.44 while the NASDAQ fell 0.98% to 13,621.46. The S&P also fell, dropping 0.54% to 4,185.22.

AAP

Read More
1 minute read
  • Media
  • News
  • Penny Stocks
  • Small Cap
  • Tech

Cleanspark, Pioneer Power Expand Contract Manufacturing Partnership; Cleanspark Becomes Think Microgrid Member

By Anusuya Lahiri
Today, 2:22 AM
Cleanspark Inc (NASDAQ:CLSK) has extended its contract manufacturing agreement with Pioneer Power Solutions, Inc (NASDAQ:PPSI). Pioneer Power can utilize Cleanspark’s proprietary software products,…

CLSK

Read More
1 minute read
  • Movers
  • Small Cap
  • Trading Ideas

Why Workhorse Stock Is Soaring Today

By Adam Eckert
Today, 2:22 AM
Workhorse Group Inc (NASDAQ: WKHS) is trading significantly higher Thursday morning as retail trader interest increases as a result of the stock's high short interest. 

AMC

Read More
4 minute read
  • Cannabis
  • Entrepreneurship
  • General
  • Markets
  • Movers & Shakers
  • News
  • Penny Stocks
  • Small Cap
  • Topics

Cannabis Movers & Shakers: The Parent Company, HempFusion, MJardin, Albert Labs, GrowGeneration, Metrc, Napalm Brands

By Jelena Martinovic
Today, 2:22 AM
The Parent Company Appoints Seven Seasoned Experts To Social Equity Fund Advisory Committee

CBDHF

Read More
1 minute read
  • Biotech
  • FDA
  • General
  • Health Care
  • News
  • Penny Stocks
  • Small Cap

Tonix Pharma Fibromyalgia Treatment Associated with Improvement in Pain, Sleep, Fatigue

By Vandana Singh
Today, 2:22 AM
Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) has announced the poster presentation of previously reported results from its Phase 3 RELIEF trial evaluating the TNX-102…

TNXP

Read More
5 minute read
  • Biotech
  • FDA
  • News
  • Offerings
  • Penny Stocks
  • Small Cap

The Daily Biotech Pulse: Merck Completes Organon Spin-Off, Auris Repositions As RNA Therapeutic Company With Trasir Purchase, Replimune’s Readout

By Shanthi Rexaline
Today, 2:22 AM
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 2)

AMYT

Read More
1 minute read
  • Biotech
  • FDA
  • General
  • Health Care
  • News
  • Small Cap

Oric Pharma’s ORIC-101 Shows Tumor Regression, Prolonged Stable Disease in Multiple Heavily Pretreated Tumors

By Vandana Singh
Today, 2:22 AM
Oric Pharmaceuticals Inc (NASDAQ:ORIC) has announced initial data from an ongoing Phase 1b study evaluating ORIC-101 in combination with nab-paclitaxel, in…

ORIC

Posts navigation

Previous 1 … 1,174 1,175 1,176 … 1,182 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service